Gerald McLaughlin, Chief Executive Officer and Director
Mr. McLaughlin was appointed President, Chief Executive Officer, and member of the Neos Board of Directors in June 2018. From June 2014 until June 2018, he was President and Chief Executive Officer of AgeneBio, a CNS biopharmaceutical company. Prior to this, Mr. McLaughlin served as the Senior Vice President and Chief Commercial Officer of NuPathe Inc. from September 2007 until its acquisition by Teva Pharmaceuticals Industries Ltd. in March 2014. Previously, Mr. McLaughlin was at Endo Pharmaceuticals from 2001 to 2007 and served in a variety of commercial leadership roles at Merck from 1990 to 2001. He holds a B.A. in Economics from Dickinson College and an M.B.A. from Villanova University.
Richard Eisenstadt, Chief Financial Officer
Richard Eisenstadt has served as our Chief Financial Officer since May 2014. Prior to joining us, he served as Chief Financial Officer of ArborGen Inc. from June 2013 to May 2014, and as Vice President of Finance and Chief Financial Officer of Tranzyme, Inc. now Ocera Therapeutics, Inc. from June 2003 to December 2012. He previously held financial leadership positions at Cogent Neuroscience, Inc. and Nimbus CD International, Inc. Mr. Eisenstadt received his M.B.A. from James Madison University and his B.A. in Economics from the University of North Carolina, Chapel Hill.
John Limongelli, Esq., Senior Vice President, General Counsel & Corporate Secretary
John Limongelli has served as our Senior Vice President, General Counsel and Corporate Secretary since March 2019. Prior to joining us, he was Senior Vice President, General Counsel & Chief Administrative Officer at Trevena, Inc. from May 2014 to March 2019. Prior to this, he was Vice President, Associate Chief Counsel and Corporate Secretary at Cigna Corporation from September 2013 until May 2014. From October 2012 to September 2013, he was a partner at a Philadelphia-area law firm, and from September 2008 to December 2011, he served as Senior Vice President, General Counsel and Secretary at Adolor Corporation. Prior to this, Mr. Limongelli held roles of increasing responsibility with Cephalon, Inc. Mr. Limongelli began his legal career in private practice with Morgan, Lewis & Bockius, LLP. Before his legal career, Mr. Limongelli was a certified public accountant with KPMG LLP. Mr. Limongelli obtained both his J.D. and M.B.A. from Temple University.
Margaret Cabano, Vice President of Operations
Margaret Cabano has 15 years of industry experience and leads all aspects of operations, supply chain and production including responsibilities for customer management, planning and project management. Prior to joining Neos, Ms. Cabano worked in operations and supply chain management for Adams Respiratory Therapeutics and Cardinal Health. Ms. Cabano holds an MBA in Operations Management Science and a Bachelor of Science in Supply Chain Logistics from the University of North Texas.
Joe Calarco, Chief Compliance Officer
Joe Calarco has served as Chief Compliance Officer since February 2018. Prior to joining Neos, Joe served in leadership roles at Bristol-Myers Squibb and Shire Pharmaceuticals where he developed and led compliance risk assessment and monitoring activities across multiple business units. Joe received his B.S. in Psychology from Drexel University and Master of Social Service from Bryn Mawr College.
Sarah Foster, Vice President of Human Resources
Sarah Foster has served as our Vice President of Human Resources since August 2019. Prior to joining Neos, Sarah was Vice President of Human Resources at Galera Therapeutics from January 2019 to August 2019. Ms. Foster was at Trevena, most recently as Vice President of Human Resources, from October 2014 through December 2018. Ms. Foster was an HR Business Partner in the Global Specialty R&D organization at Teva Pharmaceuticals from March 2012 through October 2014 and a member of the Human Resources team at Adolor Corporation from February 2005 to January 2012. Sarah holds a B.S. in Psychology from Arizona State University.
Darren Heath, Vice President of Sales
Darren Heath has served as Vice President of Sales since November 2018. Darren has an accomplished track record of success over his 25 year career having served in numerous sales leadership roles across a variety of therapeutic areas, including neurology, pain management, and gastroenterology. Prior to joining Neos, Darren worked with Recro Pharma, Endo Pharmaceuticals, Eisai, and GlaxoSmithKline. He holds a BS in Accounting from John Brown University.
Steven Lutz, Vice President of Trade Sales
Steven has served as our Vice President of Sales since August 2014. He previously served as a consultant for us from April 2014 to June 2014. Previously, Mr. Lutz served as the President and Chief Executive Officer of Praelia Pharmaceuticals, Inc. from October 2011 to March 2014. Mr. Lutz was a founder of Cornerstone Therapeutics, Inc., which was subsequently acquired by Chiesi, Inc., where he served as Executive Vice President of Operations and as President of its subsidiary, Aristos Pharmaceuticals, Inc., from July 2003 to September 2011. He received his B.A. from Moravian College in Bethlehem, PA.
Russ McMahen, Senior Vice President of Research & Development
Russ McMahen has 25 years of industry experience specializing in solids, liquids and suspensions. Mr. McMahen oversees the development of new products and technology. He is the co-inventor of DTRS®, RDIM™, DVR™, DKP™, DPD™ and SLIC™ delivery technologies. At Neos, Mr. McMahen has held various positions including Senior Vice President, Research & Development, Executive Vice President of Operations and Vice President of Scientific Affairs. Prior to joining Neos, Mr. McMahen served at Zenith/Goldline Laboratories which was subsequently acquired by Ivax Pharmaceuticals. He has a Bachelor of Science degree in Chemical Engineering from Louisiana Tech University.
Asif Mughal, Vice President of Quality Assurance
Asif Mughal has over 15 years of experience of increasing responsibility in QC/QA management and leadership. In his last two assignments for West-Ward Pharmaceuticals and EMD Chemicals (an affiliate of Merck), Mr. Mughal had international and domestic quality system responsibility. Mr. Mughal earned his Bachelor Degree in chemistry from Temple University.
Greg Pyszczymuka, Vice President of Commercial Strategy and Market Access
Greg Pyszczymuka has served as Vice President of Commercial Strategy and Market Access since November 2018 and previously served as Executive Director of Channel Strategy & Access Programs. Prior to joining Neos, Greg has served in roles of increasing responsibility over a 15 year career including sales management, brand management, channel strategy, managed markets and new products planning. Greg joined Neos most recently from Aqua Pharmaceuticals (an Almirall company) and previously was with Iroko Pharmaceuticals, Zogenix, and Endo Pharmaceuticals. He holds a BS from Rutgers University and an MBA from Argosy University.
Carolyn Sikes, PhD, Vice President of Clinical Affairs
Carolyn Sikes has almost 30 years of experience in global drug development and medical affairs. Dr. Sikes held various leadership roles at Pfizer Pharmaceuticals, Inc., and has consulted for Fortune 500 pharma companies and rising biotechs. She has worked in multiple therapeutic areas, including the development of therapeutics for depression, anxiety, post-traumatic stress disorder, Alzheimer’s disease, attention-deficit/ hyperactivity disorder, schizophrenia, epilepsy, neuropathic pain and other central nervous system disorders, and has launched several blockbuster drugs. Dr. Sikes has over 100 scientific publications and presentations. She holds a PhD in Psychobiology/Neuroscience from Duke University and completed a post-doctoral fellowship in Psychoneuroendocrinology at Cornell University Medical College. Dr. Sikes joined Neos in 2010.